Wall Street Zen upgraded shares of Alset (NASDAQ:AEI – Free Report) to a sell rating in a research note published on Saturday.
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Alset in a research report on Saturday, September 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.
Read Our Latest Report on Alset
Alset Price Performance
Alset (NASDAQ:AEI – Get Free Report) last posted its quarterly earnings data on Thursday, August 14th. The company reported ($0.71) earnings per share for the quarter. The firm had revenue of $1.10 million for the quarter. Alset had a negative return on equity of 14.31% and a negative net margin of 77.86%.
Alset announced that its board has initiated a stock repurchase plan on Monday, June 23rd that allows the company to repurchase $1.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 10% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.
Insider Transactions at Alset
In other Alset news, CEO Heng Fai Ambrose Chan sold 500,000 shares of the company’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $2.67, for a total value of $1,335,000.00. Following the sale, the chief executive officer owned 31,322,903 shares in the company, valued at $83,632,151.01. This represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 62.10% of the stock is owned by corporate insiders.
About Alset
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Featured Stories
- Five stocks we like better than Alset
- Most Volatile Stocks, What Investors Need to Know
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- What is the Nikkei 225 index?
- 3 Exceptional Stocks to Build Long-Term Wealth
- Pros And Cons Of Monthly Dividend Stocks
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Receive News & Ratings for Alset Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alset and related companies with MarketBeat.com's FREE daily email newsletter.